Binding of berberine derivates to G-quadruplex: insight from a computational study

Mengxin Li1, Yalong Cong1, Yifei Qi2

  • 1Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, Shanghai Key Laboratory of Green Chemistry & Chemical Process, School of Chemistry and Molecular Engineering, East China Normal University at Shanghai, 200062, China. John.zhang@nyu.edu.

Insights

Berberine derivatives show promise as anti-cancer agents by stabilizing G-quadruplex DNA structures. Molecular simulations reveal these derivatives bind strongly, offering a new therapeutic strategy against cancer cell proliferation.

Area of Science:

  • Computational Chemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Human telomerase activity in cancer cells drives immortal proliferation.
  • Stabilizing G-quadruplex DNA structures is a potential anti-cancer therapy strategy.
  • Berberine (BER) and its derivatives show potential for G-quadruplex stabilization.

Purpose of the Study:

  • To investigate atomic interactions between G-quadruplexes and Berberine (BER) and its derivatives.
  • To evaluate the efficacy of BER derivatives as G-quadruplex stabilizers for anti-cancer therapy.
  • To provide atomic-level insights into G-quadruplex-ligand binding.

Main Methods:

  • Molecular dynamics simulations were employed to model G-quadruplex-ligand interactions.
  • Various force fields and charge models were tested for accurate simulation of charged nucleic acids.
  • Binding energies were calculated using molecular mechanics/generalized Born surface area and interaction entropy methods.

Main Results:

  • Simulations showed G-quadruplex stability increased in the presence of BER and derivatives.
  • BER derivatives exhibited higher binding affinity to G-quadruplexes than BER.
  • The first G-tetrad was identified as crucial for binding, with van der Waals interactions being most favorable.

Conclusions:

  • Berberine derivatives offer a promising therapeutic strategy by stabilizing G-quadruplexes.
  • Atomic-level insights into G-quadruplex-inhibitor interactions guide future drug design.
  • These findings contribute to developing novel anti-cancer agents targeting G-quadruplex DNA.